This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medidata Solutions Inc (MDSO)

NASDAQ: Technology

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 6.09M 16.66M 18.02M 39.40M
Operating Gains/Losses 3.00K 241.00K 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -30.55M 1.25M -15.89M 12.40M
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 874.00K
(Decrease) Increase In Payables 1.31M -457.00K -823.00K 885.00K
(Decrease) Increase In Other Current Liabilities 3.59M 11.34M 6.51M 2.56M
(Increase) Decrease In Other Working Capital 30.02M -7.46M -10.86M -22.44M
Other Non-Cash Items 32.77M 32.51M 7.58M 5.79M
Net Cash From Continuing Operations 61.62M 69.60M 13.24M 28.67M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 61.62M 69.60M 13.24M 28.67M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 80.37M 122.76M
Purchases of Property, Plant & Equipment -15.81M -30.50M -5.74M -4.41M
Acquisitions -5.47M 0.00 0.00 -5.17M
Purchases of Short-Term Investments 0.00 0.00 -109.32M -117.10M
Other Cash from Investing Activities 226.00K -4.96M 0.00 144.00K
Cash Provided by Financing Activities
Net Cash From Investing Activities -30.44M -362.74M -34.69M -3.77M
Issuance of Debt 0.00 287.50M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 9.74M 10.45M 9.33M 3.48M
Repayment of Long-Term Debt -139.00K -324.00K -381.00K -725.00K
Repurchase of Capital Stock -28.59M -10.83M -3.44M -1.71M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 5.12M -3.99M 3.40M 3.25M
Net Cash From Financing Activities -13.86M 282.81M 8.91M 4.29M
Effect of Exchange Rate Changes -120.00K -23.00K 4.00K 0.00
Net Change in Cash & Cash Equivalents 17.19M -10.36M -12.53M 29.19M

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

MDSO Medidata Solutions Inc

Chart of MDSO

Analysts Ratings for MDSO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 7 7 7
Moderate Buy 2 2 2 2
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

MDSO Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs